Breaking News Instant updates and real-time market news.

ASH

Ashland

$74.19

0.31 (0.42%)

06:12
01/14/19
01/14
06:12
01/14/19
06:12

Ashland announces leadership changes

Ashland Global Holdings announced significant changes to the composition and leadership of its board of directors, consistent with its ongoing board refreshment program. These include the addition of two new independent board members, appointment of a lead independent director and appointment of new board committee chairs. These actions were taken by the Ashland board in consultation with Neuberger Berman,one of the company's largest shareholders and a long-term Ashland shareholder of over five years, along with input from other shareholders. Neuberger Berman has agreed to vote for Ashland's nominees for election at Ashland's 2019 Annual Meeting of Stockholders on February 8.

ASH Ashland
$74.19

0.31 (0.42%)

08/02/18
FBCO
08/02/18
NO CHANGE
Target $95
FBCO
Outperform
Ashland price target raised to $95 from $86 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for Ashland to $95 from $86 following a "strong" Q3 beat on broad based strength. The analyst reiterates an Outperform rating on the shares.
12/17/18
BUCK
12/17/18
INITIATION
BUCK
Neutral
Ashland initiated with a Neutral at Buckingham
12/27/18
JPMS
12/27/18
UPGRADE
JPMS
Overweight
Ashland upgraded to Overweight from Neutral at JPMorgan
12/27/18
JPMS
12/27/18
UPGRADE
Target $86
JPMS
Overweight
Ashland upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Ashland to Overweight from Neutral with an $86 price target, citing valuation. In a research note to investors, the analyst says he thinks the recent steep price decline in the general market presents an opportunity for a good entry point into Ashland shares, which have deceased somewhat more sharply in value than the general market over the last few weeks. Zekauskas says he does not view the recent decline in the value of Ashland as company-specific, but regards it as a function of a more risk-averse market.

TODAY'S FREE FLY STORIES

BG

Bunge

$52.95

0.745 (1.43%)

07:06
01/22/19
01/22
07:06
01/22/19
07:06
Hot Stocks
Bunge says Lupo, Bachrach, Boilini won't stand for re-election to board »

As part of Bunge's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$7.54

0.11 (1.48%)

07:05
01/22/19
01/22
07:05
01/22/19
07:05
Hot Stocks
Aurinia says VOS demonstrates statistically superior efficacy versus Restasis »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

07:05
01/22/19
01/22
07:05
01/22/19
07:05
General news
Global stock markets under pressure after gloomy IMF report. »

Global stock markets…

BG

Bunge

$52.95

0.745 (1.43%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Bunge sees FY18 total segment adjusted EBIT below previously disclosed range »

The company provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPGP

IPG Photonics

$132.54

3.37 (2.61%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
IPG Photonics to acquire Padtec SND »

IPG Photonics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$126.64

1.37 (1.09%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Centene subsidiary selected by Arizona's Department of Corrections »

Centene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 28

    May

QURE

uniQure

$31.29

-0.02 (-0.06%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
uniQure announces FDA clearance of AMT-130 NDA in Huntington's disease »

uniQure N.V. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$14.21

-0.065 (-0.46%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Concert completes enrollment of 12 mg cohort in CTP-543 Phase 2a trial »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 30

    Jan

  • 12

    Feb

  • 13

    Feb

RCKT

Rocket Pharmaceuticals

$16.00

0.23 (1.46%)

07:03
01/22/19
01/22
07:03
01/22/19
07:03
Hot Stocks
Rocket Pharmaceuticals announces FDA clearance of IND application for RP-A501 »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTI

Pluristem

$1.12

(0.00%)

07:03
01/22/19
01/22
07:03
01/22/19
07:03
Hot Stocks
Pluristem to collaborate with IDF in treatment of burn injuries »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$77.14

-6.17 (-7.41%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Tilray to acquire Natura Naturals for up to C$70M »

Tilray announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$52.95

0.745 (1.43%)

, CAG

Conagra Brands

$21.58

0.34 (1.60%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Bunge names Gregory Heckman as acting CEO »

Bunge (BG) announced that…

BG

Bunge

$52.95

0.745 (1.43%)

CAG

Conagra Brands

$21.58

0.34 (1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CGEN

Compugen

$3.18

0.07 (2.25%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Compugen announces publication of preclinical data on PVRIG »

Compugen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$110.57

6.4 (6.14%)

07:00
01/22/19
01/22
07:00
01/22/19
07:00
Recommendations
Kansas City Southern analyst commentary  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$123.97

1.03 (0.84%)

06:58
01/22/19
01/22
06:58
01/22/19
06:58
Hot Stocks
Travelers reports Q4 consolidated combined ratio of 97.5% »

Fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TRV

Travelers

$123.97

1.03 (0.84%)

06:58
01/22/19
01/22
06:58
01/22/19
06:58
Hot Stocks
Travelers reports Q4 book value per share $86.84 »

Book value per share of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CONN

Conn's

$19.65

0.31 (1.60%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Recommendations
Conn's analyst commentary  »

Conn's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$12.41

-0.07 (-0.56%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Hot Stocks
Amneal Pharmaceuticals appoints Todd Branning as CFO »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TRV

Travelers

$123.97

1.03 (0.84%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Earnings
Travelers reports Q4 core EPS $2.13, consensus $2.33 »

Reports Q4 revenue $7.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

AINV

Apollo Investment

$14.51

-0.01 (-0.07%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Upgrade
Apollo Investment rating change  »

Apollo Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

IDXG

Interpace Diagnostics

$1.07

(0.00%)

, LH

LabCorp

$137.67

2.42 (1.79%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Hot Stocks
Interpace finalizes validation of third specimen of ThyGeNEX and ThyraMIR »

Interpace Diagnostics…

IDXG

Interpace Diagnostics

$1.07

(0.00%)

LH

LabCorp

$137.67

2.42 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 07

    Feb

  • 18

    May

ZBH

Zimmer Biomet

$105.33

-0.83 (-0.78%)

06:55
01/22/19
01/22
06:55
01/22/19
06:55
Recommendations
Zimmer Biomet analyst commentary  »

Zimmer Biomet price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 01

    Feb

LCI

Lannett

$7.64

0.15 (2.00%)

06:55
01/22/19
01/22
06:55
01/22/19
06:55
Hot Stocks
Lannett enters U.S. distribution agreement for Trientine Hydrochloride Capsules »

Lannett announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SDLP

Seadrill Partners

$1.77

0.07 (4.12%)

06:54
01/22/19
01/22
06:54
01/22/19
06:54
Hot Stocks
Seadrill Partners reduces dividend to 1c from 10c »

Seadrill Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$32.69

1.005 (3.17%)

06:54
01/22/19
01/22
06:54
01/22/19
06:54
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift generating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.